SCHEMBL1161537

SCHEMBL1161537

COc1ccc2c(=O)n(C)c(CCl)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.55
PDE10A Q9Y233 5/20 0.51
KDM4E B2RXH2 2/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KCNH2 Q12809 2/20 0.44
HRH3 Q9Y5N1 2/20 0.44
ALDH1A1 P00352 3/20 0.43
GFER P55789 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
USP2 O75604 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161533 0.86 CYP3A4 (0.55) CYP3A4PDE10AKDM4EALOX15TSHR
SCHEMBL30739017 0.85 PDE10A (0.47) CYP3A4PDE10AKCNH2HRH3ALDH1A1
SCHEMBL2045483 0.80 ALDH1A1 (0.46) CYP3A4KDM4EALOX15TSHRTDP1
SCHEMBL6557713 0.80 ALDH1A1 (0.48) KDM4EALDH1A1SMN1; SMN2KMT2AHDAC6
SCHEMBL31267402 0.80 ALDH1A1 (0.55) KDM4ETDP1ALDH1A1GFERSMN1; SMN2
SCHEMBL1464928 0.80 CYP3A4 (0.56) CYP3A4PDE10AKDM4ETDP1KCNH2
SCHEMBL1161873 0.77 PPARG (0.52) ALDH1A1GFERSMN1; SMN2MAPTRAB9A
SCHEMBL1161498 0.76 HDAC6 (0.64) CYP3A4PDE10AKDM4EALOX15TSHR
SCHEMBL29571733 0.76 HDAC6 (0.64) CYP3A4PDE10AKDM4EALOX15TSHR
SCHEMBL1463889 0.76 CYP3A4 (0.53) CYP3A4PDE10AKDM4EKCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed